PumpKIN is a randomized, multicenter, two-arm trial evaluating the investigational Jarvik 2015 VAD versus the EXCOR® Pediatric VAD in pediatric patients with heart failure. This study will enroll 88 subjects, 44 receiving the Jarvik 2015 and 44 receiving the EXCOR®, at up to 24 sites in the US and Canada.